Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Cardinal Health, Inc.

CAH Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of CAH by members of U.S. Congress

Politician Type Traded
Alan Armstrong Senate / R Purchase $1,001 - $15,000 Mar 27, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Feb 05, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Jan 23, 2026
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Oct 24, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Sep 05, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 May 14, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 May 05, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 Apr 08, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Mar 17, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Jan 21, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Sep 20, 2024
John James House / R Sale $1,001 - $15,000 Sep 04, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 02, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 02, 2024
John James House / R Purchase $1,001 - $15,000 Jun 03, 2024
John James House / R Purchase $1,001 - $15,000 May 02, 2024
Ro Khanna House / D Sale None Mar 05, 2024
Jonathan L. Jackson House / D Purchase $50,001 - $100,000 Jan 12, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 10, 2024
Ro Khanna House / D Sale Over $50,000,000 Sep 06, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 29, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Feb 10, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Jan 11, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Aug 03, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul 20, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Sale $1,001 - $15,000 Nov 09, 2021
Ro Khanna House / D Sale $1,001 - $15,000 Nov 01, 2021
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Kelly Loeffler Senate / R Sale (Full) $100,001 - $250,000 Apr 07, 2020
Kelly Loeffler Senate / R Purchase $1,001 - $15,000 Apr 07, 2020
Ro Khanna House / D Sale $1,001 - $15,000 Apr 07, 2020
Kelly Loeffler Senate / R Purchase $100,001 - $250,000 Mar 20, 2020
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Mar 18, 2020
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 16, 2019
Dean Phillips House / D Sale $1,001 - $15,000 Jun 20, 2019
Ro Khanna House / D Sale $1,001 - $15,000 Jun 03, 2019
Ro Khanna House / D Purchase $1,001 - $15,000 Apr 29, 2019
Ro Khanna House / D Purchase $1,001 - $15,000 Apr 23, 2019
Ro Khanna House / D Sale $1,001 - $15,000 Mar 26, 2019
Dean Phillips House / D Purchase $1,001 - $15,000 Feb 04, 2019
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 18, 2019
Ro Khanna House / D Sale $1,001 - $15,000 Dec 17, 2018
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 13, 2018
Ro Khanna House / D Sale $1,001 - $15,000 Jun 15, 2018
Ro Khanna House / D Sale $1,001 - $15,000 May 15, 2018
Ro Khanna House / D Purchase $1,001 - $15,000 Apr 03, 2018
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 05, 2018
Bob Gibbs House / R Sale $1,001 - $15,000 Feb 27, 2018
CAH Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
CAH Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CAH Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in CAH holdings by institutional investors

Quarterly net insider trading by CAH's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $460,000 Jul 20, 2026 Issue: Health Issues Manufacturing Trade (domestic/foreign) Tariff (miscellaneous tariff bills)
  • $1,320,000 Apr 20, 2026 Issue: Health Issues Manufacturing Trade (domestic/foreign) Tariff (miscellaneous tariff bills)
  • $740,000 Jan 20, 2026 Issue: Health Issues Manufacturing Trade (domestic/foreign) Tariff (miscellaneous tariff bills)
  • $450,000 Oct 22, 2025 Issue: Tariff (miscellaneous tariff bills) Health Issues Manufacturing Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $390,000 Oct 17, 2025 Issue: Health Issues Manufacturing Trade (domestic/foreign) Tariff (miscellaneous tariff bills)
  • $1,070,000 Apr 21, 2025 Issue: Health Issues Manufacturing Taxation/Internal Revenue Code Trade (domestic/foreign) Tariff (miscellaneous tariff bills)
  • $500,000 Jan 17, 2025 Issue: Energy/Nuclear Health Issues Disaster Planning/Emergencies Manufacturing Civil Rights/Civil Liberties Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $220,000 Oct 18, 2024 Issue: Communications/Broadcasting/Radio/TV Taxation/Internal Revenue Code Civil Rights/Civil Liberties Manufacturing Disaster Planning/Emergencies Health Issues Energy/Nuclear
  • $720,000 Jul 19, 2024 Issue: Taxation/Internal Revenue Code Civil Rights/Civil Liberties Manufacturing Disaster Planning/Emergencies Health Issues Tariff (miscellaneous tariff bills) Energy/Nuclear
  • $410,000 Jan 22, 2024 Issue: Manufacturing Disaster Planning/Emergencies Health Issues Tariff (miscellaneous tariff bills) Energy/Nuclear
  • $220,000 Oct 18, 2023 Issue: Manufacturing Disaster Planning/Emergencies Civil Rights/Civil Liberties Health Issues Tariff (miscellaneous tariff bills) Energy/Nuclear
  • $200,000 Jul 20, 2023 Issue: Manufacturing Disaster Planning/Emergencies Civil Rights/Civil Liberties Health Issues Tariff (miscellaneous tariff bills) Energy/Nuclear
  • $410,000 Jan 20, 2023 Issue: Railroads Budget/Appropriations Manufacturing Disaster Planning/Emergencies Civil Rights/Civil Liberties Health Issues Tariff (miscellaneous tariff bills) Energy/Nuclear
  • $210,000 Oct 19, 2022 Issue: Budget/Appropriations Manufacturing Disaster Planning/Emergencies Civil Rights/Civil Liberties Health Issues Tariff (miscellaneous tariff bills) Energy/Nuclear
  • $260,000 Jul 20, 2022 Issue: Budget/Appropriations Manufacturing Disaster Planning/Emergencies Civil Rights/Civil Liberties Health Issues Tariff (miscellaneous tariff bills) Energy/Nuclear
  • $950,000 Apr 20, 2022 Issue: Budget/Appropriations Government Issues Manufacturing Disaster Planning/Emergencies Civil Rights/Civil Liberties Health Issues Tariff (miscellaneous tariff bills) Energy/Nuclear
  • $670,000 Jan 20, 2022 Issue: None
  • $390,000 Oct 19, 2021 Issue: None
  • $650,000 Jul 20, 2021 Issue: None
  • $780,000 Apr 20, 2021 Issue: None
  • $710,000 Jan 20, 2021 Issue: None
  • $560,000 Oct 20, 2020 Issue: None
  • $340,000 Jul 16, 2020 Issue: None
  • $950,000 Apr 20, 2020 Issue: None
  • $780,000 Jan 20, 2020 Issue: None
  • $620,000 Oct 18, 2019 Issue: Budget/Appropriations Health Issues Disaster Planning/Emergencies Civil Rights/Civil Liberties Alcohol and Drug Abuse Defense Tariff (miscellaneous tariff bills) Energy/Nuclear Medical/Disease Research/Clinical Labs
  • $550,000 Jul 17, 2019 Issue: Medical/Disease Research/Clinical Labs Tariff (miscellaneous tariff bills) Energy/Nuclear Disaster Planning/Emergencies Defense Alcohol and Drug Abuse Civil Rights/Civil Liberties Health Issues Budget/Appropriations
  • $780,000 Apr 18, 2019 Issue: Civil Rights/Civil Liberties Energy/Nuclear Tariff (miscellaneous tariff bills) Disaster Planning/Emergencies Defense Alcohol and Drug Abuse Health Issues Medical/Disease Research/Clinical Labs Budget/Appropriations
  • $970,000 Jan 17, 2019 Issue: Medical/Disease Research/Clinical Labs Energy/Nuclear Budget/Appropriations Disaster Planning/Emergencies Alcohol and Drug Abuse Defense Health Issues Tariff (miscellaneous tariff bills)
  • $790,000 Oct 17, 2018 Issue: Medical/Disease Research/Clinical Labs Tariff (miscellaneous tariff bills) Energy/Nuclear Health Issues Taxation/Internal Revenue Code Alcohol and Drug Abuse Defense Budget/Appropriations Disaster Planning/Emergencies Veterans
  • $520,000 Jul 19, 2018 Issue: Medical/Disease Research/Clinical Labs Tariff (miscellaneous tariff bills) Budget/Appropriations Veterans Health Issues Disaster Planning/Emergencies Taxation/Internal Revenue Code Alcohol and Drug Abuse Defense Energy/Nuclear
  • $540,000 Apr 18, 2018 Issue: Taxation/Internal Revenue Code Defense Energy/Nuclear Budget/Appropriations Health Issues Veterans Medical/Disease Research/Clinical Labs Alcohol and Drug Abuse Disaster Planning/Emergencies
  • $520,000 Jan 18, 2018 Issue: Energy/Nuclear Health Issues Alcohol and Drug Abuse Disaster Planning/Emergencies Veterans Medical/Disease Research/Clinical Labs Defense Taxation/Internal Revenue Code
  • $500,000 Oct 18, 2017 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies Taxation/Internal Revenue Code Alcohol and Drug Abuse Defense Veterans Health Issues Energy/Nuclear
  • $360,000 Jul 17, 2017 Issue: Medical/Disease Research/Clinical Labs Energy/Nuclear Veterans Health Issues Taxation/Internal Revenue Code Alcohol and Drug Abuse
  • $370,000 Apr 19, 2017 Issue: Alcohol and Drug Abuse Energy/Nuclear Taxation/Internal Revenue Code Veterans Medical/Disease Research/Clinical Labs Health Issues
  • $290,000 Jan 19, 2017 Issue: Medical/Disease Research/Clinical Labs Energy/Nuclear Veterans Taxation/Internal Revenue Code Alcohol and Drug Abuse Health Issues
  • $340,000 Oct 17, 2016 Issue: Medical/Disease Research/Clinical Labs Energy/Nuclear Veterans Health Issues Alcohol and Drug Abuse Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $290,000 Jul 15, 2016 Issue: Medical/Disease Research/Clinical Labs Energy/Nuclear Veterans Taxation/Internal Revenue Code Alcohol and Drug Abuse Health Issues Trade (domestic/foreign)
  • $270,000 Apr 19, 2016 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Alcohol and Drug Abuse Trade (domestic/foreign) Medical/Disease Research/Clinical Labs Energy/Nuclear
  • $220,000 Jan 20, 2016 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Alcohol and Drug Abuse Trade (domestic/foreign) Energy/Nuclear Medical/Disease Research/Clinical Labs
  • $870,000 Oct 20, 2015 Issue: Medical/Disease Research/Clinical Labs Energy/Nuclear Taxation/Internal Revenue Code Alcohol and Drug Abuse Medicare/Medicaid
  • $310,000 Jul 20, 2015 Issue: Taxation/Internal Revenue Code Alcohol and Drug Abuse Medicare/Medicaid Medical/Disease Research/Clinical Labs Energy/Nuclear
  • $1,090,000 Apr 20, 2015 Issue: Energy/Nuclear Medicare/Medicaid Taxation/Internal Revenue Code Alcohol and Drug Abuse Medical/Disease Research/Clinical Labs
  • $260,000 Jan 19, 2015 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code Alcohol and Drug Abuse Trade (domestic/foreign)
  • $780,000 Oct 21, 2014 Issue: Pharmacy Taxation/Internal Revenue Code Medicare/Medicaid
  • $410,000 Jul 21, 2014 Issue: Health Issues Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid
  • $620,000 Apr 19, 2014 Issue: Health Issues Taxation/Internal Revenue Code Pharmacy
  • $380,000 Jan 21, 2014 Issue: Pharmacy Health Issues Taxation/Internal Revenue Code
  • $960,000 Oct 21, 2013 Issue: Pharmacy Health Issues Taxation/Internal Revenue Code
  • $360,000 Jul 15, 2013 Issue: Pharmacy Health Issues Taxation/Internal Revenue Code
  • $230,000 Apr 22, 2013 Issue: Health Issues Taxation/Internal Revenue Code Pharmacy
  • $310,000 Jan 21, 2013 Issue: Health Issues Taxation/Internal Revenue Code
  • $610,000 Oct 22, 2012 Issue: Pharmacy Health Issues Taxation/Internal Revenue Code
  • $875,000 Jul 20, 2012 Issue: Pharmacy Health Issues Taxation/Internal Revenue Code
  • $370,000 Apr 20, 2012 Issue: Pharmacy Health Issues
  • $235,000 Jan 20, 2012 Issue: Health Issues Pharmacy
  • $670,000 Oct 19, 2011 Issue: Health Issues Taxation/Internal Revenue Code Financial Institutions/Investments/Securities
  • $350,000 Jul 20, 2011 Issue: Health Issues Taxation/Internal Revenue Code
  • $180,000 Apr 20, 2011 Issue: Health Issues Medicare/Medicaid
  • $135,000 Jan 17, 2011 Issue: Medicare/Medicaid Health Issues
  • $540,000 Oct 20, 2010 Issue: Health Issues Medicare/Medicaid
  • $300,000 Jul 19, 2010 Issue: Health Issues Medicare/Medicaid
  • $320,000 Apr 19, 2010 Issue: Health Issues
  • $160,000 Jan 20, 2010 Issue: Health Issues
  • $390,000 Oct 19, 2009 Issue: Medicare/Medicaid Energy/Nuclear Health Issues
  • $190,000 Jul 19, 2009 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Pharmacy
  • $195,000 Apr 20, 2009 Issue: Medicare/Medicaid Pharmacy
  • $180,000 Jan 20, 2009 Issue: Homeland Security Pharmacy Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $320,000 Oct 20, 2008 Issue: Medical/Disease Research/Clinical Labs Homeland Security Pharmacy Medicare/Medicaid
  • $230,000 Jul 18, 2008 Issue: Homeland Security Medicare/Medicaid Pharmacy Medical/Disease Research/Clinical Labs
  • $200,000 Apr 18, 2008 Issue: Medicare/Medicaid Homeland Security Medical/Disease Research/Clinical Labs
  • $580,000 Feb 14, 2008 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $1,000,400 Aug 13, 2007 Issue: Medicare/Medicaid Pharmacy
  • $760,000 Aug 01, 2007 Issue: Manufacturing Health Issues Medicare/Medicaid Pharmacy Medical/Disease Research/Clinical Labs Science/Technology
  • $320,000 Aug 08, 2006 Issue: Medicare/Medicaid
  • $140,000 Feb 14, 2006 Issue: Medicare/Medicaid
  • $130,000 Aug 09, 2005 Issue: Manufacturing Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid Pharmacy Science/Technology
  • $140,000 Feb 08, 2005 Issue: Manufacturing Health Issues Science/Technology Medicare/Medicaid Pharmacy Medical/Disease Research/Clinical Labs
  • $220,000 Aug 18, 2004 Issue: Manufacturing Medical/Disease Research/Clinical Labs Science/Technology Health Issues Medicare/Medicaid Pharmacy
  • $100,000 Apr 16, 2004 Issue: Medicare/Medicaid Manufacturing Health Issues Pharmacy Medical/Disease Research/Clinical Labs Science/Technology
  • $120,000 Aug 06, 2003 Issue: Pharmacy Medical/Disease Research/Clinical Labs Science/Technology Manufacturing Health Issues Medicare/Medicaid
  • $120,000 Mar 14, 2003 Issue: Science/Technology Manufacturing Health Issues Medicare/Medicaid Pharmacy Medical/Disease Research/Clinical Labs
  • $20,000 Aug 13, 2002 Issue: Manufacturing Medicare/Medicaid Pharmacy Medical/Disease Research/Clinical Labs Science/Technology
  • $40,000 Feb 28, 2002 Issue: Pharmacy Medical/Disease Research/Clinical Labs Science/Technology Medicare/Medicaid Manufacturing Health Issues
  • $60,000 Aug 13, 2001 Issue: Health Issues
  • $40,000 Feb 15, 2001 Issue: Health Issues Pharmacy Medical/Disease Research/Clinical Labs
  • $900,000 Aug 15, 2000 Issue: Health Issues
  • $80,000 Aug 09, 2000 Issue: Science/Technology Medical/Disease Research/Clinical Labs Pharmacy Medicare/Medicaid Health Issues Manufacturing
  • $60,000 Feb 14, 2000 Issue: Science/Technology Manufacturing Health Issues Medicare/Medicaid Pharmacy Medical/Disease Research/Clinical Labs
  • $80,000 Feb 14, 2000 Issue: Health Issues
  • $820,000 Aug 13, 1999 Issue: Health Issues

Former government officials who have lobbied for CAH

51 former government officials from 28 congressional offices at 12 lobbying firms have lobbied for CAH, most recently Jul 20, 2026.

  • John Stone House Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C Formerly Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Steven Pfrang House COS, Rep. LaHood; Dep COS, LD, Rep. Reed; LA, LC, SA, Intern, Rep. Fossella Formerly LaHood · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Roger F. Wicker
    Joseph Lai Senate Sp. Asst. to POTUS for Leg Affairs; LD Sen. Wicker; Mil. Leg. Asst. Sen Wicker; Policy Advisor Sen. Voinovich; Policy Advisor Sen. Hagel; Intern U.S. Trade and Development Agency Formerly with Roger F. Wicker · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Sam Gejdenson
    Maya Seiden House Intern, WH Counsels Office; Intern, Rep. Sam Gejdenson; Sp. Asst to Cab Sec., WH; Advisor to CoS, Energy Dept.; Sp Asst to Sec of Energy; Sen Advisor, Off of Dep. Sec of State; CoS Office of the Dep Sec of State for Management and Res. Formerly with Sam Gejdenson · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Elizabeth Warren
    Remy Mason Senate Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz Formerly with Elizabeth Warren · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • James Williams Other Special Assist. to the Pres., WH Domestic Policy Council, 2019-2021; Economist, WH Council of Economic Advisors, 2017-2019 Formerly Special Assist. to the Pres., WH Domestic Policy Council, 2019-2021; Economist, · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Ron Wyden
    Raghav Aggarwal Senate Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of Interior Formerly with Ron Wyden · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Charlie Chapman House Policy Advisor, HHS; Special Asst, HHS; Prof Staff Member, House Budget Committee; LA, House Budget Committee; Staff Asst, House Ways and Means Committee; Intern, House Ways and Means Committee Formerly Policy Advisor, HHS; Special Asst, HHS; Prof Staff Member, House Budget Committe · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
See all 51 on the Revolving Door dashboard

CAH Estimated quarterly lobbying spending

CAH Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
CAH Income Statement
CAH Balance Sheet
CAH Cash Flow
U.S. Patents

New CAH patent grants

  • Patent Title: Pharmaceutical distribution systems and methods May. 17, 2011
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to CAH from public contracts

CAH News

Recent insights relating to CAH

CNBC Recommendations

Recent picks made for CAH stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CAH

CAH Analyst Ratings

CAH Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
CAH Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $CAH stock a Buy, Sell, or Hold?

  • What is the price target for $CAH stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

CAH Top Shareholders
Shareholder
Shares Held
CAH Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $CAH stock?

  • Who owns the most shares of $CAH stock?

  • What funds own $CAH stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

CAH Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CAH Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About CAH

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

  • Address Dublin, OH
  • Market Cap 51.5 billion
  • Employees 63,900
  • Industrial Classification Wholesale-Drugs, Proprietaries & Druggists' Sundries

Cardinal Health, Inc. (CAH) Historical Stock Prices

Cardinal Health, Inc. (CAH) closed at $222.62 on September 24, 2026. Over the past year its adjusted close ranged from $147.44 to $248.61. Daily prices go back to January 2, 2014, 3,201 trading days in all.

  • 1 month-6.43%
  • 3 months-4.96%
  • Year to date+9.10%
  • 1 year+45.51%
  • 3 years+161.36%
  • 5 years+385.14%
  • Max+365.66%
See every congressional and insider trade on the CAH price chart

Quiver Premium charts CAH's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 222.08 225.37 221.95 222.62 222.62 3,480,950
Sep 23, 2026 221.79 225.64 220.94 221.27 221.27 1,215,982
Sep 22, 2026 227.17 228.44 221.21 222.04 222.04 2,776,268
Sep 21, 2026 225.28 227.58 223.54 225.75 225.75 1,189,139
Sep 18, 2026 225.29 226.12 221.70 225.38 225.38 4,143,251
Sep 17, 2026 232.71 232.71 226.02 226.34 226.34 2,260,544
Sep 16, 2026 233.07 234.90 232.09 232.54 232.54 1,220,657
Sep 15, 2026 233.89 234.83 230.34 232.65 232.65 1,796,366
Sep 14, 2026 236.76 237.56 232.60 234.89 234.89 2,165,472
Sep 11, 2026 238.77 239.43 232.60 234.57 234.57 1,111,693
Sep 10, 2026 241.27 242.12 235.67 236.02 236.02 1,216,480
Sep 9, 2026 239.02 241.64 238.41 240.00 240.00 1,029,091
Sep 8, 2026 243.90 245.83 239.43 240.49 240.49 1,596,749
Sep 4, 2026 246.34 249.29 246.29 247.18 247.18 1,548,359
Sep 3, 2026 246.11 249.26 245.82 248.61 248.61 1,387,112
Sep 2, 2026 240.99 246.02 239.35 245.49 245.49 1,363,900
Sep 1, 2026 236.85 240.75 236.03 239.35 239.35 1,336,386
Aug 31, 2026 234.92 236.97 233.51 234.62 234.62 1,673,454
Aug 28, 2026 236.02 236.80 233.72 234.55 234.55 1,779,203
Aug 27, 2026 236.49 237.30 234.15 235.13 235.13 1,033,994
Aug 26, 2026 237.90 240.88 236.44 238.40 238.40 1,473,077
Aug 25, 2026 232.51 238.10 232.38 237.92 237.92 1,335,050
Aug 24, 2026 229.16 232.37 227.68 232.37 232.37 1,400,370
Aug 21, 2026 228.80 231.29 228.16 229.51 229.51 1,386,835
Aug 20, 2026 232.25 235.00 228.38 228.46 228.46 1,592,926
Aug 19, 2026 236.41 238.15 232.34 234.85 234.85 1,375,021
Aug 18, 2026 235.17 238.24 233.94 234.98 234.98 1,792,652
Aug 17, 2026 233.55 238.94 233.55 235.66 235.66 1,802,012
Aug 14, 2026 230.91 235.27 229.33 235.17 235.17 1,687,833
Aug 13, 2026 233.00 235.67 229.36 231.24 231.24 2,845,419
Aug 12, 2026 239.75 239.75 233.49 234.16 234.16 1,914,166
Aug 11, 2026 243.00 258.30 236.48 240.26 240.26 3,007,925
Aug 10, 2026 236.32 239.54 235.00 237.18 237.18 2,297,337
Aug 7, 2026 237.23 239.85 236.30 236.40 236.40 1,551,067
Aug 6, 2026 244.01 244.87 233.99 237.66 237.66 1,796,517
Aug 5, 2026 235.13 239.54 235.01 239.23 239.23 2,650,974
Aug 4, 2026 234.31 235.76 231.14 233.55 233.55 2,579,228
Aug 3, 2026 230.39 235.72 229.60 235.60 235.60 2,094,489
Jul 31, 2026 226.66 231.23 225.39 230.03 230.03 1,738,180
Jul 30, 2026 226.28 227.78 224.11 227.07 227.07 1,484,267
Jul 29, 2026 234.02 234.02 228.49 229.12 229.12 2,746,159
Jul 28, 2026 232.09 233.77 230.32 232.51 232.51 2,652,244
Jul 27, 2026 227.78 230.61 227.03 229.35 229.35 1,106,324
Jul 24, 2026 227.88 228.97 225.97 228.03 228.03 1,466,731
Jul 23, 2026 220.56 226.01 220.54 225.98 225.98 1,837,736
Jul 22, 2026 227.30 229.85 220.37 220.54 220.54 2,521,778
Jul 21, 2026 225.99 227.63 225.02 227.09 227.09 1,595,261
Jul 20, 2026 229.20 229.24 225.49 225.75 225.75 1,711,834
Jul 17, 2026 230.54 233.22 228.43 228.52 228.52 2,053,095
Jul 16, 2026 225.74 229.13 223.07 228.72 228.72 2,607,844
Jul 15, 2026 228.71 230.23 224.52 224.94 224.94 2,358,354
Jul 14, 2026 231.80 231.83 227.85 230.11 230.11 3,127,439
Jul 13, 2026 236.14 237.38 233.15 233.66 233.66 2,286,108
Jul 10, 2026 233.07 236.26 232.05 235.80 235.80 2,842,646
Jul 9, 2026 238.39 240.22 231.83 233.77 233.77 3,216,490
Jul 8, 2026 239.06 240.91 236.87 237.15 237.15 2,693,642
Jul 7, 2026 240.12 243.21 237.99 239.71 239.71 3,236,463
Jul 6, 2026 241.86 241.86 233.81 237.52 237.52 2,476,985
Jul 2, 2026 239.79 240.91 237.53 238.94 238.94 2,039,275
Jul 1, 2026$0.5158 dividend 238.87 239.71 233.00 237.72 237.72 1,369,779
Jun 30, 2026 237.00 239.53 236.40 237.56 237.05 1,666,875
Jun 29, 2026 239.93 240.93 235.15 236.22 235.71 1,926,695
Jun 26, 2026 237.78 240.44 236.00 237.92 237.41 3,633,366
Jun 25, 2026 232.52 237.79 232.38 234.75 234.24 2,074,443
Jun 24, 2026 229.89 235.71 229.43 233.01 232.51 2,354,370
Jun 23, 2026 225.21 229.26 222.50 228.91 228.41 2,110,477
Jun 22, 2026 223.73 228.45 222.28 222.74 222.26 2,886,148
Jun 18, 2026 226.17 226.17 219.47 221.77 221.29 4,196,190
Jun 17, 2026 226.00 229.54 224.48 226.28 225.79 2,249,232
Jun 16, 2026 227.30 229.78 225.37 227.72 227.23 3,027,719
Jun 15, 2026 222.78 226.66 221.03 226.40 225.91 2,397,334
Jun 12, 2026 222.47 224.88 222.11 223.85 223.37 2,198,498
Jun 11, 2026 217.49 223.87 217.04 221.16 220.68 2,834,231
Jun 10, 2026 214.00 218.96 211.45 216.30 215.83 3,820,693
Jun 9, 2026 203.24 212.83 202.04 212.67 212.21 3,190,454
Jun 8, 2026 203.14 206.41 201.00 204.48 204.04 1,534,780
Jun 5, 2026 203.08 207.55 203.08 205.71 205.26 1,591,019
Jun 4, 2026 198.90 201.95 197.53 201.74 201.30 2,338,392
Jun 3, 2026 196.09 198.07 195.51 195.85 195.43 1,212,654
Jun 2, 2026 194.20 195.89 194.20 194.88 194.46 1,786,994
Jun 1, 2026 195.36 196.85 194.00 195.15 194.73 2,032,172
May 29, 2026 201.35 201.51 196.20 196.80 196.37 3,132,473
May 28, 2026 199.54 201.89 197.61 199.85 199.42 1,916,380
May 27, 2026 200.59 201.47 199.29 199.84 199.41 1,628,262
May 26, 2026 200.00 201.44 199.25 200.37 199.94 1,714,940
May 22, 2026 201.98 202.77 199.69 200.68 200.25 1,537,350
May 21, 2026 198.07 201.24 197.88 200.61 200.18 2,063,241
May 20, 2026 199.61 201.06 198.58 199.23 198.80 1,756,927
May 19, 2026 200.79 203.98 199.60 200.37 199.94 2,804,377
May 18, 2026 195.32 201.80 195.32 199.77 199.34 2,413,953
May 15, 2026 194.76 197.05 193.73 195.20 194.78 3,715,526
May 14, 2026 186.44 194.49 186.44 194.38 193.96 3,623,465
May 13, 2026 181.51 186.56 180.45 186.35 185.95 2,848,945
May 12, 2026 182.74 185.74 181.75 182.56 182.16 2,322,064
May 11, 2026 184.50 185.76 181.92 182.50 182.10 2,012,675
May 8, 2026 185.35 190.24 182.87 183.65 183.25 3,260,786
May 7, 2026 191.60 192.39 185.01 185.28 184.88 3,102,882
May 6, 2026 192.00 195.00 187.22 191.49 191.07 4,429,441
May 5, 2026 197.71 198.38 195.01 197.00 196.57 1,363,974
May 4, 2026 193.51 200.40 193.51 197.06 196.63 2,240,789
May 1, 2026 196.37 196.71 191.97 195.24 194.82 2,093,367
Apr 30, 2026 195.29 197.22 185.80 192.88 192.46 4,542,153
Apr 29, 2026 204.53 204.90 201.08 202.82 202.38 1,684,615
Apr 28, 2026 204.73 206.61 202.85 205.61 205.16 1,525,233
Apr 27, 2026 199.44 203.59 199.44 202.34 201.90 2,129,091
Apr 24, 2026 203.78 203.95 198.56 199.85 199.42 1,402,420
Apr 23, 2026 200.83 205.62 200.01 204.72 204.28 1,428,900
Apr 22, 2026 205.00 205.44 197.06 200.55 200.12 2,518,489
Apr 21, 2026 210.50 211.03 204.58 204.92 204.48 1,564,014
Apr 20, 2026 213.25 215.00 210.48 211.18 210.72 1,368,837
Apr 17, 2026 212.12 214.59 210.09 213.99 213.53 1,962,322
Apr 16, 2026 211.01 214.02 210.51 213.10 212.64 1,163,723
Apr 15, 2026 213.69 214.23 211.03 211.83 211.37 1,337,435
Apr 14, 2026 213.02 216.46 212.70 214.95 214.49 1,407,207
Apr 13, 2026 215.93 217.47 212.65 214.18 213.72 1,394,787
Apr 10, 2026 215.03 216.09 211.84 215.52 215.05 1,292,233
Apr 9, 2026 214.74 217.77 214.33 215.80 215.33 1,051,316
Apr 8, 2026 213.19 216.45 211.66 215.13 214.66 1,265,281
Apr 7, 2026 211.37 214.14 210.39 212.77 212.31 1,449,937
Apr 6, 2026 213.13 213.55 210.99 212.62 212.16 1,171,974
Apr 2, 2026 211.51 214.56 210.45 214.05 213.59 1,503,836
Apr 1, 2026$0.5107 dividend 211.36 213.42 210.08 212.02 211.56 1,462,899
Mar 31, 2026 208.40 211.72 207.29 211.31 210.35 1,587,255
Mar 30, 2026 209.10 209.96 205.71 206.31 205.37 1,513,732
Mar 27, 2026 207.86 208.18 205.35 206.58 205.64 1,307,106
Mar 26, 2026 210.23 211.97 207.19 207.70 206.75 1,599,992
Mar 25, 2026 208.00 212.22 207.91 211.31 210.35 1,836,886
Mar 24, 2026 206.91 208.72 203.86 207.23 206.28 1,983,734
Mar 23, 2026 209.98 211.10 205.78 206.40 205.46 2,579,321
Mar 20, 2026 211.11 212.12 206.70 207.83 206.88 4,250,998
Mar 19, 2026 212.23 214.50 210.28 210.92 209.96 1,424,737
Mar 18, 2026 215.73 216.21 210.45 211.87 210.90 1,756,809
Mar 17, 2026 217.94 218.87 211.13 216.36 215.37 1,772,404
Mar 16, 2026 218.67 220.23 216.89 217.59 216.60 1,731,499
Mar 13, 2026 219.62 222.58 216.17 217.08 216.09 1,422,643
Mar 12, 2026 217.18 221.28 215.72 219.09 218.09 2,053,766
Mar 11, 2026 216.08 217.01 214.43 215.42 214.44 1,126,365
Mar 10, 2026 221.13 222.62 216.43 217.04 216.05 1,568,036
Mar 9, 2026 217.40 222.38 214.90 222.28 221.27 2,555,598
Mar 6, 2026 216.00 220.22 213.58 217.78 216.79 2,090,346
Mar 5, 2026 222.10 222.38 215.89 216.02 215.03 2,847,666
Mar 4, 2026 226.34 226.34 221.74 223.18 222.16 1,701,689
Mar 3, 2026 228.00 228.98 222.29 226.35 225.32 2,398,296
Mar 2, 2026 232.04 233.60 228.08 229.88 228.83 1,751,094
Feb 27, 2026 227.94 230.20 226.93 229.23 228.18 2,066,917
Feb 26, 2026 226.50 229.50 226.50 227.13 226.09 1,167,143
Feb 25, 2026 226.05 226.99 225.04 226.18 225.15 878,565
Feb 24, 2026 224.52 226.05 220.89 225.97 224.94 1,434,936
Feb 23, 2026 224.41 228.04 224.00 224.82 223.79 1,351,838
Feb 20, 2026 222.97 224.49 220.51 224.44 223.42 1,072,631
Feb 19, 2026 224.98 225.56 221.25 222.76 221.74 885,038
Feb 18, 2026 225.34 225.90 222.59 224.99 223.96 1,050,386
Feb 17, 2026 221.71 225.91 221.71 225.58 224.55 1,696,701
Feb 13, 2026 216.40 221.72 216.40 220.79 219.78 1,116,912
Feb 12, 2026 225.17 229.15 213.75 215.06 214.08 3,167,439
Feb 11, 2026 220.96 225.87 219.72 224.25 223.23 1,313,504
Feb 10, 2026 226.00 227.05 219.58 220.27 219.26 1,445,360
Feb 9, 2026 226.56 228.17 225.28 225.76 224.73 1,420,005
Feb 6, 2026 226.21 230.81 226.16 226.32 225.29 2,250,733
Feb 5, 2026 217.00 229.76 212.03 227.18 226.14 3,583,568
Feb 4, 2026 215.52 217.76 205.87 206.85 205.91 2,504,363
Feb 3, 2026 218.70 220.27 217.16 218.00 217.00 1,890,452
Feb 2, 2026 215.85 218.93 214.50 218.93 217.93 1,645,127
Jan 30, 2026 210.95 214.92 210.01 214.88 213.90 2,454,212
Jan 29, 2026 212.46 216.51 210.29 211.23 210.27 1,306,988
Jan 28, 2026 212.62 214.33 208.46 210.39 209.43 1,507,957
Jan 27, 2026 210.60 214.59 210.01 214.04 213.06 1,771,789
Jan 26, 2026 208.86 212.16 208.86 210.93 209.97 1,824,191
Jan 23, 2026 207.04 210.75 206.67 208.33 207.38 2,159,908
Jan 22, 2026 209.00 209.84 206.27 206.89 205.95 1,742,690
Jan 21, 2026 209.22 210.79 206.32 208.47 207.52 1,849,898
Jan 20, 2026 210.48 213.38 209.28 210.37 209.41 1,654,240
Jan 16, 2026 213.62 214.52 212.00 212.45 211.48 1,331,389
Jan 15, 2026 213.65 215.48 212.92 213.46 212.49 1,785,516
Jan 14, 2026 208.53 213.63 207.85 213.56 212.59 1,598,873
Jan 13, 2026 210.10 212.30 205.65 208.26 207.31 1,913,549
Jan 12, 2026 202.00 203.33 199.94 202.52 201.60 1,511,408
Jan 9, 2026 203.79 204.34 200.55 201.11 200.19 1,285,020
Jan 8, 2026 207.90 209.77 201.67 202.49 201.57 1,585,577
Jan 7, 2026 208.09 211.77 206.22 207.19 206.25 2,035,445
Jan 6, 2026 205.47 209.44 205.06 208.48 207.53 1,513,752
Jan 5, 2026 203.81 206.39 201.02 205.45 204.51 2,743,417
Jan 2, 2026$0.511 dividend 204.57 205.76 203.01 205.72 204.78 1,165,702
Dec 31, 2025 207.48 208.14 205.49 205.50 204.06 1,094,239
Dec 30, 2025 207.94 208.89 207.19 207.21 205.75 1,225,684
Dec 29, 2025 208.03 208.51 207.13 207.38 205.92 808,002
Dec 26, 2025 207.70 208.44 207.11 208.29 206.83 591,039
Dec 24, 2025 207.38 209.07 207.26 207.54 206.08 704,234
Dec 23, 2025 204.59 207.90 204.30 207.37 205.91 1,300,206
Dec 22, 2025 203.31 205.44 202.00 205.20 203.76 1,916,569
Dec 19, 2025 200.74 202.95 200.38 202.95 201.52 4,173,157
Dec 18, 2025 198.83 200.90 197.56 199.10 197.70 2,488,733
Dec 17, 2025 198.19 199.37 196.53 198.44 197.04 2,581,378
Dec 16, 2025 199.24 199.67 195.54 197.89 196.50 2,250,068
Dec 15, 2025 198.81 200.83 198.10 199.96 198.55 3,004,033
Dec 12, 2025 198.26 199.08 197.46 198.18 196.79 2,746,296
Dec 11, 2025 197.93 199.30 197.46 198.32 196.93 1,086,740
Dec 10, 2025 198.86 199.76 197.36 198.21 196.82 1,397,447
Dec 9, 2025 200.71 202.22 197.80 198.00 196.61 2,143,220
Dec 8, 2025 199.01 199.69 198.17 198.88 197.48 2,198,787
Dec 5, 2025 199.76 200.25 198.10 198.83 197.43 1,738,751
Dec 4, 2025 199.64 200.68 197.81 199.19 197.79 2,810,152
Dec 3, 2025 205.55 206.70 198.75 199.71 198.31 5,171,297
Dec 2, 2025 208.00 208.97 203.26 205.13 203.69 3,610,317
Dec 1, 2025 212.88 213.54 207.86 208.00 206.54 1,830,592
Nov 28, 2025 213.32 214.07 212.03 212.26 210.77 817,830
Nov 26, 2025 213.70 214.93 212.54 213.14 211.64 1,808,716
Nov 25, 2025 212.49 214.62 212.49 213.73 212.23 1,343,958
Nov 24, 2025 209.27 213.03 208.30 211.20 209.72 3,438,063
Nov 21, 2025 208.02 210.32 207.40 209.48 208.01 3,095,115
Nov 20, 2025 207.91 209.57 206.10 207.90 206.44 2,588,864
Nov 19, 2025 206.33 209.57 205.52 207.52 206.06 2,751,859
Nov 18, 2025 207.05 207.76 203.84 206.97 205.51 2,079,276
Nov 17, 2025 205.40 208.18 204.13 206.18 204.73 2,026,893
Nov 14, 2025 206.85 208.32 204.69 205.37 203.93 2,524,512
Nov 13, 2025 202.96 207.05 201.59 206.06 204.61 2,182,291
Nov 12, 2025 203.95 204.96 202.34 204.32 202.88 2,513,760
Nov 11, 2025 204.96 207.47 203.77 204.81 203.37 1,966,295
Nov 10, 2025 200.90 205.48 199.90 205.43 203.99 2,111,272
Nov 7, 2025 199.91 203.67 197.19 203.67 202.24 5,013,950
Nov 6, 2025 197.62 198.30 194.81 197.99 196.60 2,571,744
Nov 5, 2025 196.50 200.14 194.15 196.79 195.41 2,608,777
Nov 4, 2025 190.43 196.96 189.70 195.34 193.97 3,906,692
Nov 3, 2025 191.07 192.47 188.15 190.22 188.88 2,503,802
Oct 31, 2025 192.07 197.67 190.24 190.77 189.43 4,080,725
Oct 30, 2025 181.44 195.15 181.44 189.84 188.51 7,173,517
Oct 29, 2025 163.23 164.71 161.64 164.47 163.31 2,816,509
Oct 28, 2025 163.50 164.07 161.97 162.79 161.65 2,067,583
Oct 27, 2025 163.06 163.82 161.35 163.80 162.65 1,796,924
Oct 24, 2025 159.14 162.19 158.70 161.89 160.75 1,823,220
Oct 23, 2025 159.85 162.00 158.93 159.16 158.04 1,414,803
Oct 22, 2025 159.30 160.50 157.79 159.52 158.40 2,247,506
Oct 21, 2025 157.96 158.93 156.81 158.68 157.56 1,776,831
Oct 20, 2025 157.12 158.23 155.84 157.27 156.16 1,154,414
Oct 17, 2025 152.56 156.45 152.46 156.41 155.31 1,930,994
Oct 16, 2025 155.35 157.64 153.11 153.27 152.19 1,760,372
Oct 15, 2025 154.18 156.56 154.18 155.67 154.58 1,491,878
Oct 14, 2025 154.34 154.45 151.87 154.19 153.11 2,316,361
Oct 13, 2025 156.30 157.35 154.21 154.31 153.22 1,757,815
Oct 10, 2025 157.84 158.39 156.70 156.88 155.78 1,602,155
Oct 9, 2025 157.77 158.45 156.32 157.21 156.10 1,584,348
Oct 8, 2025 156.75 157.99 155.66 157.77 156.66 1,292,589
Oct 7, 2025 155.19 156.68 153.31 156.65 155.55 1,316,281
Oct 6, 2025 153.27 156.15 152.13 155.19 154.10 1,425,229
Oct 3, 2025 158.22 159.24 150.78 154.46 153.37 6,613,455
Oct 2, 2025 156.33 158.72 156.00 158.46 157.35 3,219,091
Oct 1, 2025$0.511 dividend 155.81 158.82 155.40 157.93 156.82 3,714,947
Sep 30, 2025 154.34 157.70 153.03 156.96 155.35 3,050,738
Sep 29, 2025 153.17 155.74 152.83 154.57 152.99 3,199,444
Sep 26, 2025 149.85 153.93 149.59 153.71 152.14 1,709,652
Sep 25, 2025 154.69 154.93 145.87 148.96 147.44 3,164,908
Sep 24, 2025 154.13 157.01 153.85 154.58 153.00 2,655,444

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Cardinal Health, Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at CAH, per a recent SEC DEF 14A filing. We estimate that the median employee at CARDINAL HEALTH INC is paid $56,119.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation